bioRxivImmunology
Comprehensive cell surface proteomics defines markers of classical, intermediate and non-classical monocytes
B. J. Ravenhill, L. Soday, J. Houghton, R. Antrobus, M. P. Weekes
Abstract
Monocytes are a critical component of the cellular innate immune system, and can be subdivided into classical, intermediate and non-classical subsets on the basis of surface CD14 and CD16 expression. Classical monocytes play the canonical role of phagocytosis, and account for the majority of circulating cells. Intermediate and non-classical cells are known to exhibit varying levels of phagocytosis and cytokine secretion, and are differentially expanded in certain pathological states. Characterisation of cell surface proteins expressed by each subset is informative not only to improve understanding of phenotype, but may also provide biological insights into function. Here we use highly multiplexed Tandem-Mass-Tag (TMT)-based mass spectrometry with selective cell surface biotinylation to characterise the classical monocyte surface proteome, then interrogate the phenotypic differences between each monocyte subset to identify novel protein markers.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Pro-inflammatory response of non-inflammatory Classical monocytes stimulated with LPS in vitro.
C. A. Karsulovic, F. Tempio, … A. Goecke·bioRxiv·May 4, 2020
- Characterizing the polarization continuum of macrophage subtypes M1, M2a and M2c
T. C. Oates, P. L. Moura, … A. M. Toye·bioRxiv·Jun 13, 2022
- In vitro and in vivo derived macrophages occupy distinct phenotypic states
Stéphane Chevrier, Vito RT Zanotelli, … Bernd Bodenmiller·bioRxiv·Sep 20, 2025
- Single-Cell Proteomics Study of Immune Cell Diversity by Quantitating 465 Proteins
- Defining the cell surface proteomic landscape of multiple myeloma reveals immunotherapeutic strategies and biomarkers of drug resistance
I. D. Ferguson, B. P. Escobar, … A. P. Wiita·bioRxiv·Jan 17, 2021
- Interplay of Monocytes and T Lymphocytes in COVID-19 Severity
L. E. Padgett, H. Q. Dinh, … C. C. Hedrick·bioRxiv·Jul 17, 2020